Treatment of Superficial Basal Cell Carcinoma by Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Topical Photodynamic Therapy With Methylaminolevulinate
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Hexyl aminolevulinate (Primary) ; Methyl aminolevulinate (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 09 Feb 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2011-005809-77).
- 31 Jan 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
- 19 Dec 2011 New trial record